Ruzurgi (2021-09-09)
- Starting date:
- September 9, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76465
Last updated:
2021-09-20
Summary
-
Product:
Ruzurgi
Reason
Total combinated yeasts and molds count (TYMC) is out of specification in the affected lot.
Depth of distribution
Wholesalers, Retailers, End users.
Affected products
Ruzurgi
DIN, NPN, DIN-HIM
DIN 02503034
Dosage form
Tablet
Strength
Amifampridine 10 mg
Lot or serial number
18038
Companies
- Recalling Firm
-
Medunik Canada
950 Michèle-Bohec
Blainville
J7C 5E2
Quebec
CANADA
- Marketing Authorization Holder
-
Medunik Canada
950 Michèle-Bohec
Blainville
J7C 5E2
Quebec
CANADA